Literature DB >> 29523312

Diagnostic performance of an optimized transcriptomic signature of risk of tuberculosis in cryopreserved peripheral blood mononuclear cells.

Fatoumatta Darboe1, Stanley Kimbung Mbandi1, Ethan G Thompson2, Michelle Fisher1, Miguel Rodo3, Michele van Rooyen1, Elizabeth Filander1, Nicole Bilek1, Simbarashe Mabwe1, Mark Hatherill1, Daniel E Zak2, Adam Penn-Nicholson1, Thomas J Scriba4.   

Abstract

Entities:  

Keywords:  Biomarker; Correlate of risk; Diagnostic; PBMC; Whole blood; mRNA

Mesh：

Substances：

Year:  2017        PMID： 29523312     DOI： 10.1016/j.tube.2017.11.001

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN： 1472-9792            Impact factor:   3.131


× No keyword cloud information.
  15 in total

1.  Building capacity for advances in tuberculosis research; proceedings of the third RePORT international meeting.

Authors:  Yuri F van der Heijden; Fareed Abdullah; Bruno B Andrade; Jason R Andrews; Devasahayam J Christopher; Julio Croda; Heather Ewing; David W Haas; Mark Hatherill; C Robert Horsburgh; Vidya Mave; Helder I Nakaya; Valeria Rolla; Sudha Srinivasan; Retna Indah Sugiyono; Cesar Ugarte-Gil; Carol Hamilton
Journal:  Tuberculosis (Edinb)       Date:  2018-10-01       Impact factor: 3.131

2.  Peripheral Blood Mucosal-Associated Invariant T Cells in Tuberculosis Patients and Healthy Mycobacterium tuberculosis-Exposed Controls.

Authors:  Sara Suliman; Anele Gela; Simon C Mendelsohn; Sarah K Iwany; Kattya Lopez Tamara; Simbarashe Mabwe; Nicole Bilek; Fatoumatta Darboe; Michelle Fisher; Alexandra J Corbett; Lars Kjer-Nielsen; Sidonia B G Eckle; Chuan-Chin Huang; Zibiao Zhang; David M Lewinsohn; James McCluskey; Jamie Rossjohn; Mark Hatherill; Segundo R León; Roger I Calderon; Leonid Lecca; Megan Murray; Thomas J Scriba; Ildiko Van Rhijn; D Branch Moody
Journal:  J Infect Dis       Date:  2020-08-17       Impact factor: 5.226

3.  Potential population level impact on tuberculosis incidence of using an mRNA expression signature correlate-of-risk test to target tuberculosis preventive therapy.

Authors:  Tom Sumner; Thomas J Scriba; Adam Penn-Nicholson; Mark Hatherill; Richard G White
Journal:  Sci Rep       Date:  2019-07-31       Impact factor: 4.379

4.  Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial.

Authors:  Thomas J Scriba; Andrew Fiore-Gartland; Adam Penn-Nicholson; Humphrey Mulenga; Stanley Kimbung Mbandi; Bhavesh Borate; Simon C Mendelsohn; Katie Hadley; Chris Hikuam; Masooda Kaskar; Munyaradzi Musvosvi; Nicole Bilek; Steven Self; Tom Sumner; Richard G White; Mzwandile Erasmus; Lungisa Jaxa; Rodney Raphela; Craig Innes; William Brumskine; Andriëtte Hiemstra; Stephanus T Malherbe; Razia Hassan-Moosa; Michèle Tameris; Gerhard Walzl; Kogieleum Naidoo; Gavin Churchyard; Mark Hatherill
Journal:  Lancet Infect Dis       Date:  2021-01-25       Impact factor: 71.421

5.  Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL): A cross-sectional observational study protocol using respondent driven sampling.

Authors:  Tara Carney; Jennifer A Rooney; Nandi Niemand; Bronwyn Myers; Danie Theron; Robin Wood; Laura F White; Christina S Meade; Novel N Chegou; Elizabeth Ragan; Gerhard Walzl; Robert Horsburgh; Robin M Warren; Karen R Jacobson
Journal:  PLoS One       Date:  2022-02-15       Impact factor: 3.752

6.  Prospective multicentre head-to-head validation of host blood transcriptomic biomarkers for pulmonary tuberculosis by real-time PCR.

Authors:  Simon C Mendelsohn; Stanley Kimbung Mbandi; Andrew Fiore-Gartland; Adam Penn-Nicholson; Munyaradzi Musvosvi; Humphrey Mulenga; Michelle Fisher; Katie Hadley; Mzwandile Erasmus; Onke Nombida; Michèle Tameris; Gerhard Walzl; Kogieleum Naidoo; Gavin Churchyard; Mark Hatherill; Thomas J Scriba
Journal:  Commun Med (Lond)       Date:  2022-03-10

7.  Longitudinal Dynamics of a Blood Transcriptomic Signature of Tuberculosis.

Authors:  Humphrey Mulenga; Munyaradzi Musvosvi; Simon C Mendelsohn; Adam Penn-Nicholson; Stanley Kimbung Mbandi; Andrew Fiore-Gartland; Michèle Tameris; Simbarashe Mabwe; Hadn Africa; Nicole Bilek; Fazlin Kafaar; Shabaana A Khader; Balie Carstens; Katie Hadley; Chris Hikuam; Mzwandile Erasmus; Lungisa Jaxa; Rodney Raphela; Onke Nombida; Masooda Kaskar; Mark P Nicol; Slindile Mbhele; Judi Van Heerden; Craig Innes; William Brumskine; Andriëtte Hiemstra; Stephanus T Malherbe; Razia Hassan-Moosa; Gerhard Walzl; Kogieleum Naidoo; Gavin Churchyard; Mark Hatherill; Thomas J Scriba
Journal:  Am J Respir Crit Care Med       Date:  2021-12-15       Impact factor: 30.528

Review 8.  Tuberculous Meningitis: Pathogenesis, Immune Responses, Diagnostic Challenges, and the Potential of Biomarker-Based Approaches.

Authors:  Charles M Manyelo; Regan S Solomons; Gerhard Walzl; Novel N Chegou
Journal:  J Clin Microbiol       Date:  2021-02-18       Impact factor: 5.948

Review 9.  Venomous Arachnid Diagnostic Assays, Lessons from Past Attempts.

Authors:  Camila Dias-Lopes; Ana Luiza Paiva; Clara Guerra-Duarte; Franck Molina; Liza Felicori
Journal:  Toxins (Basel)       Date:  2018-09-10       Impact factor: 4.546

10.  Plasma Type I IFN Protein Concentrations in Human Tuberculosis.

Authors:  Alba Llibre; Nicole Bilek; Vincent Bondet; Fatoumatta Darboe; Stanley Kimbung Mbandi; Adam Penn-Nicholson; Mark Hatherill; Flore Rozenberg; Thomas J Scriba; Darragh Duffy
Journal:  Front Cell Infect Microbiol       Date:  2019-08-22       Impact factor: 5.293
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.